Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_assertion type Assertion NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_head.
- NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_assertion description "[Finally, among gynecologic carcinomas with cytoplasmic clearing, HNF1B immunostaining was linked to a 3.0-fold increased risk of clinically-significant venous thrombosis (P = 0.043), and with a 2.3-fold increased risk (P = 0.011) in a combined gynecologic and renal carcinoma cohort.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_provenance.
- NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_assertion evidence source_evidence_literature NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_provenance.
- NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_assertion SIO_000772 24040285 NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_provenance.
- NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_assertion wasDerivedFrom befree-2016 NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_provenance.
- NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_assertion wasGeneratedBy ECO_0000203 NP1111237.RAdzGMCrBKBGw7aFHn6qs1saRle3RB56ghrMp7ab_kgug130_provenance.